Custom procedure packs are regulated as medical devices under the same frameworks that govern their individual components. In the EU, the primary regulation is the Medical Device Regulation (EU) 2017/745, commonly referred to as the EU MDR, which sets out specific obligations for anyone who assembles, labels, or places a procedure pack on the market. Understanding who carries which obligation, and how component-level standards feed into pack-level compliance, is what this article unpacks.
Who is responsible for regulatory compliance in a custom procedure pack?
The entity that assembles a custom procedure pack and places it on the market as a finished product carries primary regulatory responsibility. Under the EU MDR, this assembler is treated as the manufacturer of the pack for regulatory purposes, regardless of whether the individual components were already CE marked. Each component supplier remains responsible for the compliance of their own product.
This distinction matters in practice. A company that sources CE-marked surgical drapes, adhesive tapes, incision films, and other single-use items and combines them into a single-use surgical pack takes on the obligations of a system or procedure pack assembler. That includes maintaining a technical file for the pack, applying appropriate labeling, and ensuring that combining the components does not compromise their individual intended purposes or safety profiles.
Component suppliers are not released from their own obligations when their products are incorporated into a pack. They remain responsible for the CE marking, documentation, and performance claims that apply to each item they supply. The assembler, in turn, relies on that documentation to demonstrate that the finished pack meets its regulatory requirements.
What does EU MDR Article 22 require for procedure pack assemblers?
EU MDR Article 22 defines the obligations that apply specifically to system and procedure pack assemblers. Assemblers who combine CE-marked devices without changing their intended purpose must register with the relevant competent authority, compile a declaration of conformity for the pack, and keep that documentation available for inspection. They are not required to obtain a new CE mark for the pack itself, provided all components already carry one.
However, Article 22 sets out conditions that must all be satisfied for this simplified pathway to apply:
- All devices included in the pack must be CE marked and used within their intended purpose.
- The combination of devices must not compromise their individual safety or performance.
- The pack must be labeled with the assembler’s name, trade name, and address.
- The assembler must compile and retain the declaration of conformity and make it available to competent authorities on request.
If the assembler sterilizes the pack, additional requirements apply. Sterilization must be carried out according to a validated method, and the assembler must follow the applicable annex of the EU MDR relating to sterile packs. This is a significant additional obligation and typically requires engagement with a notified body.
If any component in the pack is not CE marked, or if the assembler modifies a component’s intended purpose, the entire pack must go through the full conformity assessment process as a new medical device. This is a critical threshold that assemblers need to assess carefully before finalizing their pack contents.
Do custom procedure packs need CE marking?
A custom procedure pack assembled entirely from CE-marked components, used within their intended purposes, does not require a separate CE mark for the pack itself under EU MDR Article 22. Instead, the assembler issues a declaration of conformity and labels the pack with their own details. The CE marks of the individual components remain valid and collectively support the pack’s regulatory status.
The situation changes if the pack includes any non-CE-marked device, or if the assembly process alters a component in a way that goes beyond its original intended purpose. In those cases, the assembler must treat the pack as a new device, conduct a full conformity assessment, involve a notified body where required, and apply a CE mark to the finished pack.
For manufacturers supplying components to pack assemblers, this means the CE marking status of each supplied item directly affects the compliance pathway available to their customers. Supplying fully documented, CE-marked components simplifies the assembler’s regulatory process considerably.
How does ISO 13485 affect custom procedure pack compliance?
ISO 13485 is the international quality management standard for medical device manufacturers. While it is not a legal requirement under the EU MDR in the way that CE marking is, it serves as the recognized framework for demonstrating that a quality management system meets the regulation’s requirements. Most notified bodies and competent authorities expect manufacturers and assemblers to operate under ISO 13485 certification.
For procedure pack assemblers, ISO 13485 affects compliance in several practical ways:
- Supplier qualification: ISO 13485 requires assemblers to evaluate and qualify their component suppliers. This means reviewing supplier quality systems, certificates, and technical documentation before incorporating their products.
- Traceability: The standard requires documented traceability throughout the supply chain, so that any quality issue can be traced back to a specific component lot or supplier.
- Change control: Any change to pack contents, component suppliers, or manufacturing processes must go through a formal change control procedure, with an assessment of whether the change affects regulatory status.
- Document control: Technical files, declarations of conformity, and supplier documentation must be maintained under a controlled system and kept available for the required retention period.
For component suppliers, holding ISO 13485 certification makes it easier for assemblers to qualify them quickly. It signals that the supplier operates a documented quality system with consistent process controls, which reduces the due diligence burden on the assembler’s side.
What labeling requirements apply to custom procedure packs?
Custom procedure packs must be labeled in accordance with EU MDR Annex I, Chapter III, which sets out general labeling requirements for medical devices. At minimum, the label must include the assembler’s name and registered address, the pack name or reference, a unique device identifier (UDI) where applicable, the intended purpose if not obvious, any warnings or precautions, the expiry date or shelf life, and an indication of whether the pack is sterile.
The UDI requirement deserves particular attention. The EU MDR introduced mandatory UDI labeling on a phased timeline, and by 2026, the requirements apply broadly across device classes. Procedure pack assemblers must register their packs in the EUDAMED database and apply UDI carriers to the pack label in accordance with the applicable standard.
Language requirements also apply. Labels must be in the official language or languages of the member state where the pack is placed on the market. For packs distributed across multiple EU countries, this often means multi-language labeling or country-specific label variants.
Individual components within the pack retain their own labels, but the outer pack label is the assembler’s responsibility. The assembler cannot simply rely on component labels to satisfy the pack-level labeling obligation.
Which component standards must adhesive products in procedure packs meet?
Adhesive products used in custom procedure packs, such as surgical tapes, incision films, and adhesive drape fixation components, must meet the requirements of the EU MDR as medical devices in their own right. This includes biocompatibility assessment in accordance with the ISO 10993 series, which evaluates cytotoxicity, sensitization, and skin irritation for products that contact the patient or the surgical field.
Beyond biocompatibility, relevant standards for adhesive components include:
- ISO 10993-5 and ISO 10993-10: Cytotoxicity and sensitization testing, foundational requirements for any skin-contacting adhesive.
- EN 13726 series: Where applicable to absorbent or contact layer properties, though more directly relevant to wound management than surgical drapes.
- ISO 11135 / ISO 11137: Sterilization standards, applicable if the adhesive component is supplied sterile or if the pack is sterilized after assembly.
- EN 13795: The standard for surgical drapes, gowns, and clean air suits, which sets performance requirements for surgical barrier products. Adhesive components integrated into drapes must not compromise the barrier performance tested under this standard.
For pack assemblers, verifying that each adhesive component supplier can provide the relevant test reports and declarations of conformity is part of the supplier qualification process required under ISO 13485. A component that lacks documented biocompatibility testing creates a gap in the pack’s technical file that can delay market access or trigger regulatory scrutiny.
How SOMED supports procedure pack compliance
Navigating the regulatory requirements for custom procedure packs is easier when your adhesive components arrive with the documentation already in place. At SOMED, we manufacture surgical adhesive tapes and films, including our OP Tape and OP Film product lines, specifically for integration into single-use surgical packs and nonwoven surgical drapes.
Here is what we provide to support your compliance process:
- CE-marked components: All SOMED adhesive products are CE marked and MDR compliant, so they fit directly into the Article 22 pathway for procedure pack assemblers.
- ISO 13485 quality system: Our manufacturing and quality management processes operate under ISO 13485, which supports your supplier qualification requirements.
- Technical documentation: We supply the documentation you need for your technical file, including declarations of conformity and relevant test data.
- Custom development: If your pack requires an adhesive solution that does not yet exist, we can develop it with you. Our in-house R&D and laboratory capabilities mean we can work at relatively small volumes, so you do not need to commit to large runs to explore a new format.
- On-site support: We offer on-site assistance to help integrate our products into your pack assembly process correctly.
If you are developing or refining a custom procedure pack and want to discuss how our adhesive components can fit your regulatory and performance requirements, get in touch with our team directly.
This content was generated with the help of AI and it may contain mistakes